Clinical Trial Update: Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on retifanlimab, alone or in combination with other therapies, for advanced or metastatic endometrial cancer after platinum-based …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Retifanlimab (retifanlimab)

Snippet

Sponsor: Incyte Corporation | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING